Diabetogenic transferrin damages podocytes in early human diabetic nephropathy

被引:5
|
作者
Gonzalez, S
Vargas, L
机构
[1] Pontificia Univ Catolica Chile, Fac Biol Sci, Dept Cellular & Mol Biol, Santiago 1, Chile
[2] Pontificia Univ Catolica Chile, Sch Med, Dept Pathol, Santiago 1, Chile
关键词
growth hormone; transferrin; podocyte; diabetic nephropathy;
D O I
10.1055/s-2001-12406
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The exact mechanisms by which growth hormone (GH) damages the kidney inducing diabetic nephropathy has not yet been elucidated. Recently, it has been shown that transferrin has the same diabetogenic effects of GH, being its mediator. Transferrin was studied using immunohistochemistry and immunoelectron microscopy in cases of early diabetic nephropathy, and in controls. Transferrin was only found in diabetic cases in podocytes and Bowman's capsule cells, but also in the tubular cells of both diabetic and non-diabetic controls. Immune-electron microscopy for the presence of transferrin showed positive signals in the cytoplasm of diabetic podocytes, but not in pedicels. This selective deposition was associated with signs of organelle and cytoskeleton damage. On the basis of previous evidence and present glomerular findings, these results suggest an indirect diabetogenic effect on the kidney by GH mediated through transferrin.
引用
收藏
页码:84 / 88
页数:5
相关论文
共 50 条
  • [1] URINARY EXCRETION OF PODOCYTES AS AN EARLY MARKER OF DIABETIC NEPHROPATHY
    Sharma, Shuchita
    Bonal, Dennis
    Thomas, David
    Jim, Belinda
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2010, 55 (04) : A102 - A102
  • [2] Urinary transferrin as an early biomarker of diabetic nephropathy
    Terzic, Brankica
    Stanojevic, Ivan
    Radojicic, Zoran
    Resan, Mirko
    Petrovic, Dejan
    Maksic, Djoko
    Djekic, Jelena
    Ristic, Petar
    Petrovic, Milica
    Mijuskovic, Mirjana
    VOJNOSANITETSKI PREGLED, 2019, 76 (06) : 615 - 619
  • [3] Protective effects of tacrolimus on podocytes in early diabetic nephropathy in rats
    Peng, Tao
    Chang, Xiangdi
    Wang, Jie
    Zhen, Junhui
    Yang, Xiangdong
    Hu, Zhao
    MOLECULAR MEDICINE REPORTS, 2017, 15 (05) : 3172 - 3178
  • [4] VEGF and Podocytes in Diabetic Nephropathy
    Tufro, Alda
    Veron, Delma
    SEMINARS IN NEPHROLOGY, 2012, 32 (04) : 385 - 393
  • [5] PODOCYTES AND DIABETIC NEPHROPATHY AN UPDATE
    Tarek, Abdelaziz
    NEPHROLOGY, 2014, 19 : 154 - 154
  • [6] Sirolimus damages podocytes in rats with protein overload nephropathy
    Cai, Yong
    Chen, Yan
    Zheng, Shaoling
    Chen, Bicheng
    Yang, Yirong
    Xia, Peng
    JOURNAL OF NEPHROLOGY, 2011, 24 (03) : 307 - 312
  • [7] Epigenetic Alterations in Podocytes in Diabetic Nephropathy
    Sugita, Erina
    Hayashi, Kaori
    Hishikawa, Akihito
    Itoh, Hiroshi
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [8] Nicotine, smoking, podocytes, and diabetic nephropathy
    Jaimes, Edgar A.
    Zhou, Ming-Sheng
    Siddiqui, Mohammed
    Rezonzew, Gabriel
    Tian, Runxia
    Seshan, Surya, V
    Muwonge, Alecia N.
    Wong, Nicholas J.
    Azeloglu, Evren U.
    Fornoni, Alessia
    Merscher, Sandra
    Raij, Leopoldo
    AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2021, 320 (03) : F442 - F453
  • [9] Podocytes and mesangial cells in diabetic nephropathy
    Wolf, G.
    FEBS JOURNAL, 2009, 276 : 76 - 76
  • [10] Hypertrophy and Loss of Podocytes in Diabetic Nephropathy
    Miyauchi, Masaaki
    Toyoda, Masao
    Kobayashi, Keiko
    Abe, Makiko
    Kobayashi, Takako
    Kato, Mayuko
    Yamamoto, Naoyuki
    Kimura, Moritsugu
    Umezono, Tomoya
    Suzuki, Daisuke
    INTERNAL MEDICINE, 2009, 48 (18) : 1615 - 1620